Integer (ITGR) Competitors

Biodesix (NASDAQ:BDSX) and Integer (NYSE:ITGR) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings and media sentiment.

Which has more volatility & risk, BDSX or ITGR?

Biodesix has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500. Comparatively, Integer has a beta of 1.02, indicating that its share price is 2% more volatile than the S&P 500.

Which has preferable earnings and valuation, BDSX or ITGR?

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biodesix	$71.32M	0.92	-$42.93M	-$0.29	-1.54
Integer	$1.72B	2.16	$119.90M	$2.27	46.58

Does the media favor BDSX or ITGR?

In the previous week, Integer had 1 more articles in the media than Biodesix. MarketBeat recorded 5 mentions for Integer and 4 mentions for Biodesix. Integer's average media sentiment score of 1.03 beat Biodesix's score of 0.00 indicating that Integer is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biodesix	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Integer	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is BDSX or ITGR more profitable?

Integer has a net margin of 4.61% compared to Biodesix's net margin of -54.28%. Integer's return on equity of 12.27% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biodesix	-54.28%	-167.28%	-39.96%
Integer	4.61%	12.27%	6.23%

Do institutionals and insiders have more ownership in BDSX or ITGR?

21.0% of Biodesix shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 30.1% of Biodesix shares are owned by company insiders. Comparatively, 2.2% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Do analysts recommend BDSX or ITGR?

Biodesix presently has a consensus target price of $1.75, indicating a potential upside of 291.50%. Integer has a consensus target price of $140.25, indicating a potential upside of 32.64%. Given Biodesix's higher probable upside, equities analysts plainly believe Biodesix is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biodesix	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
Integer	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	3.00

Summary

Integer beats Biodesix on 15 of the 17 factors compared between the two stocks.